These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15061044)

  • 1. Low level laser therapy for treatment of primary and secondary Raynaud's phenomenon.
    al-Awami M; Schillinger M; Maca T; Pollanz S; Minar E
    Vasa; 2004 Feb; 33(1):25-9. PubMed ID: 15061044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low level laser treatment of primary and secondary Raynaud's phenomenon.
    al-Awami M; Schillinger M; Gschwandtner ME; Maca T; Haumer M; Minar E
    Vasa; 2001 Nov; 30(4):281-4. PubMed ID: 11771213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low level laser therapy in primary Raynaud's phenomenon--results of a placebo controlled, double blind intervention study.
    Hirschl M; Katzenschlager R; Francesconi C; Kundi M
    J Rheumatol; 2004 Dec; 31(12):2408-12. PubMed ID: 15570642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind, randomised, placebo controlled low level laser therapy study in patients with primary Raynaud's phenomenon.
    Hirschl M; Katzenschlager R; Ammer K; Melnizky P; Rathkolb O; Kundi M
    Vasa; 2002 May; 31(2):91-4. PubMed ID: 12099151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: a multicenter, placebo-controlled, double-blind study.
    Wigley FM; Korn JH; Csuka ME; Medsger TA; Rothfield NF; Ellman M; Martin R; Collier DH; Weinstein A; Furst DE; Jimenez SA; Mayes MD; Merkel PA; Gruber B; Kaufman L; Varga J; Bell P; Kern J; Marrott P; White B; Simms RW; Phillips AC; Seibold JR
    Arthritis Rheum; 1998 Apr; 41(4):670-7. PubMed ID: 9550476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thermographic parameters in the diagnosis of secondary Raynaud's phenomenon.
    Schuhfried O; Vacariu G; Lang T; Korpan M; Kiener HP; Fialka-Moser V
    Arch Phys Med Rehabil; 2000 Apr; 81(4):495-9. PubMed ID: 10768542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Raynaud's phenomenon with the selective serotonin reuptake inhibitor fluoxetine.
    Coleiro B; Marshall SE; Denton CP; Howell K; Blann A; Welsh KI; Black CM
    Rheumatology (Oxford); 2001 Sep; 40(9):1038-43. PubMed ID: 11561116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Losartan therapy for Raynaud's phenomenon and scleroderma: clinical and biochemical findings in a fifteen-week, randomized, parallel-group, controlled trial.
    Dziadzio M; Denton CP; Smith R; Howell K; Blann A; Bowers E; Black CM
    Arthritis Rheum; 1999 Dec; 42(12):2646-55. PubMed ID: 10616013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modified-release sildenafil reduces Raynaud's phenomenon attack frequency in limited cutaneous systemic sclerosis.
    Herrick AL; van den Hoogen F; Gabrielli A; Tamimi N; Reid C; O'Connell D; Vázquez-Abad MD; Denton CP
    Arthritis Rheum; 2011 Mar; 63(3):775-82. PubMed ID: 21360507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of patients with severe secondary Raynaud's phenomenon with the endothelin receptor antagonist bosentan.
    Selenko-Gebauer N; Duschek N; Minimair G; Stingl G; Karlhofer F
    Rheumatology (Oxford); 2006 Oct; 45 Suppl 3():iii45-8. PubMed ID: 16987835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy.
    Fries R; Shariat K; von Wilmowsky H; Böhm M
    Circulation; 2005 Nov; 112(19):2980-5. PubMed ID: 16275885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled multicenter double blind trial of an oral analog of prostacyclin in the treatment of primary Raynaud's phenomenon. French Microcirculation Society Multicentre Group for the Study of Vascular Acrosyndromes.
    Vayssairat M
    J Rheumatol; 1996 Nov; 23(11):1917-20. PubMed ID: 8923366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous N-acetylcysteine for treatment of Raynaud's phenomenon secondary to systemic sclerosis: a pilot study.
    Sambo P; Amico D; Giacomelli R; Matucci-Cerinic M; Salsano F; Valentini G; Gabrielli A
    J Rheumatol; 2001 Oct; 28(10):2257-62. PubMed ID: 11669166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placebo controlled study showing therapeutic benefit of iloprost in the treatment of Raynaud's phenomenon.
    Kyle MV; Belcher G; Hazleman BL
    J Rheumatol; 1992 Sep; 19(9):1403-6. PubMed ID: 1279169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infrared-monitored cold response in the assessment of Raynaud's phenomenon.
    Foerster J; Wittstock S; Fleischanderl S; Storch A; Riemekasten G; Hochmuth O; Meffert B; Meffert H; Worm M
    Clin Exp Dermatol; 2006 Jan; 31(1):6-12. PubMed ID: 16309469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cold stimulus fingertip lacticemy test--an effective method to monitor acute therapeutic intervention on primary Raynaud's phenomenon and systemic sclerosis.
    Fontenelle SM; Kayser C; Pucinelli ML; Andrade LE
    Rheumatology (Oxford); 2008 Jan; 47(1):80-3. PubMed ID: 18077495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the effect of sildenafil on the microvascular blood flow in patients with systemic sclerosis: a randomised, double-blind, placebo-controlled study.
    Andrigueti FV; Ebbing PCC; Arismendi MI; Kayser C
    Clin Exp Rheumatol; 2017; 35 Suppl 106(4):151-158. PubMed ID: 28281457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins: potentially useful in therapy of systemic sclerosis-related Raynaud's phenomenon and digital ulcers.
    Abou-Raya A; Abou-Raya S; Helmii M
    J Rheumatol; 2008 Sep; 35(9):1801-8. PubMed ID: 18709692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of the cold challenge on the discriminatory capacity of the digital distal-dorsal difference in the thermographic assessment of Raynaud's phenomenon.
    Pauling JD; Flower V; Shipley JA; Harris ND; McHugh NJ
    Microvasc Res; 2011 Nov; 82(3):364-8. PubMed ID: 21420982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laser Doppler-recorded venoarteriolar reflex in Raynaud's phenomenon.
    Stoyneva Z
    Auton Neurosci; 2004 Nov; 116(1-2):62-8. PubMed ID: 15556839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.